A detailed history of Peak6 Investments LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 19,500 shares of EOLS stock, worth $311,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,500
Previous 19,700 1.02%
Holding current value
$311,025
Previous $275,000 23.27%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$10.45 - $13.76 $20,617 - $27,148
1,973 Added 362.68%
2,517 $27,000
Q1 2024

May 14, 2024

SELL
$9.99 - $14.91 $143,786 - $214,599
-14,393 Reduced 96.36%
544 $7,000
Q4 2023

Feb 13, 2024

SELL
$7.6 - $10.53 $67,130 - $93,011
-8,833 Reduced 37.16%
14,937 $157,000
Q3 2023

Nov 13, 2023

BUY
$7.15 - $10.2 $59,552 - $84,955
8,329 Added 53.94%
23,770 $217,000
Q2 2023

Aug 11, 2023

BUY
$7.23 - $10.52 $111,638 - $162,439
15,441 New
15,441 $112,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $895M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.